Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Transcode Therapeutics, Inc. (RNAZ)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
20 Jun 2023
Dudley Robert Michael
Chief Executive Officer, Director, Officer
Transcode Therapeutics, Inc.
(RNAZ)
82,262
+29%
18,607
$2.62
$48,664.53
BUY
9 Jun 2023
Dudley Robert Michael
Chief Executive Officer, Director, Officer
Transcode Therapeutics, Inc.
(RNAZ)
912,114
+2%
19,000
$2.76
$52,440.00
BUY
9 Jun 2023
Dudley Robert Michael
Chief Executive Officer, Director, Officer
Transcode Therapeutics, Inc.
(RNAZ)
61,155
+45%
19,000
$2.76
$52,440.00
BUY
14 Sep 2022
Dudley Robert Michael
Chief Executive Officer, Director, Officer, 10% Owner
Transcode Therapeutics, Inc.
(RNAZ)
893,114
+2%
20,000
$1.15
$23,000.00
BUY
16 Jun 2022
Fitzgerald Thomas A
Chief Financial Officer, Director, Officer
Transcode Therapeutics, Inc.
(RNAZ)
139,377
+9%
12,000
$1.27
$15,240.00
BUY
27 May 2022
Dudley Robert Michael
Chief Executive Officer, Director, Officer, 10% Owner
Transcode Therapeutics, Inc.
(RNAZ)
873,114
+3%
30,000
$1.85
$55,383.00
Home